Aaron Kesselheim
Associate Professor, Medicine, Harvard Medical School; Director, Program On Regulation, Therapeutics, And Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women’s Hospital
Meet Aaron Kesselheim
“I use empirical methods to study drug development, approval and use, with the goal of informing evidence-based policymaking in the pharmaceutical market. A key moment for me was the creation of my PORTAL program in 2012 to help build a center of activity and a cadre of researchers interested in pharmaceutical law and health services research.
I would like to see greater investment in identifying and understanding transformative innovation, combined with greater attention paid to making sure products that emerge are available to the patients and health systems that need them.”